7 completed, 4 recruiting, 3 terminated, 3 unknown. 6 Phase 1, 4 Phase 3, 3 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 2, Terminated 2, Unknown 1, Withdrawn 1 |
| Phase 3 | 4 | Completed 1, Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
Follow Pharmicell Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction Erectile Dysfunction | Recruiting | Pharmicell Co., Ltd. | 32 | 2024-12-26 | 2026-02-24 | |
| Long-Term Follow-up of Patients With Chronic Kidney Disease Treated With Cellgram-CKD Chronic Kidney Disease | Active not recruiting | Pharmicell Co., Ltd. | 10 | 2022-03-10 | 2026-09-25 | |
| Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration Hearticellgram-AMI - Acute Myocardial Infarction | Not applicable | Recruiting | Pharmicell Co., Ltd. | 100 | 2022-03-03 | 2026-02-10 |
| A Phase 1 Study of Cellgram-DC in Patients With Advanced or Recurrent Epithelial Ovarian Cancer Cellgram-DC - Ovarian Cancer, Advanced Epithelial Ovarian Cancer | Phase 1 | Terminated | Pharmicell Co., Ltd. | 2 | 2022-02-09 | 2026-09-18 |
| Phase 1 Study of Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Chronic Kidney Disease Cellgram-CKD - Chronic Kidney Disease | Phase 1 | Completed | Pharmicell Co., Ltd. | 10 | 2021-11-24 | 2026-09-25 |
| Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC Alcoholic Liver Cirrhosis | Recruiting | Pharmicell Co., Ltd. | 100 | 2021-09-09 | 2026-09-21 | |
| A Phase 1 Study of Autologous Dendritic Cell Immunotherapy in Patients With mCRPC Cellgram-DC-PC - Metastatic Castration Resistant Prostate Cancer | Phase 1 | Terminated | Pharmicell Co., Ltd. | 3 | 2021-07-05 | 2026-09-21 |
| Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis Cellgram-LC, Best Supportive Care (BSC) - Alcoholic Cirrhosis | Phase 3 | Recruiting | Pharmicell Co., Ltd. | 200 | 2021-04-19 | 2026-09-21 |
| Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously Cellgram-ED - Erectile Dysfunction | Phase 2 | Completed | Pharmicell Co., Ltd. | 54 | 2020-10-19 | 2026-02-09 |
| A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia Cellgram-CLI - Critical Limb Ischemia | Phase 1 | Withdrawn | Pharmicell Co., Ltd. | 2019-12-01 | 2019-03-22 | |
| Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC Cellgram™ (Bone marrow-derived MSCs) - Alcoholic Liver Cirrhosis | Phase 1 | Unknown | Pharmicell Co., Ltd. | 10 | 2019-06-20 | 2020-10-22 |
| Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction no Intervention - Erectile Dysfunction | Unknown | Pharmicell Co., Ltd. | 10 | 2019-03-11 | 2020-10-22 | |
| Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 Study Alcoholic Liver Cirrhosis | Completed | Pharmicell Co., Ltd. | 48 | 2016-05-01 | 2020-11-02 | |
| Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction mesenchymal stem cell - Erectile Dysfunction | Phase 1 | Completed | Pharmicell Co., Ltd. | 10 | 2015-07-01 | 2019-01-09 |
| To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction. Hearticellgram-AMI - Acute Myocardial Infarction | Phase 3 | Completed | Pharmicell Co., Ltd. | 90 | 2013-09-01 | 2026-02-09 |
| REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient) Livercellgram - Alcoholic Liver Cirrhosis | Phase 2 | Completed | Pharmicell Co., Ltd. | 72 | 2012-11-01 | 2016-03-17 |
| The STem Cell Application Researches and Trials In NeuroloGy-2 (STARTING-2) Study Mesenchymal stem cell - Stroke, Ischemic | Phase 3 | Unknown | Samsung Medical Center | 60 | 2012-11-01 | 2017-04-26 |
| Safety Study of Clinical Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction Acute Myocardial Infarction | Completed | Pharmicell Co., Ltd. | 41 | 2012-05-01 | 2019-02-15 | |
| Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury cellgram-spine - Spinal Cord Injury | Phase 2 / Phase 3 | Terminated | Pharmicell Co., Ltd. | 20 | 2008-08-01 | 2021-03-23 |
Liver Cirrhosis, Alcoholic (5) · Erectile Dysfunction (4) · Renal Insufficiency, Chronic (2) · Carcinoma, Ovarian Epithelial (1) · Chronic Limb-Threatening Ischemia (1) · Fibrosis (1) · Ischemic Stroke (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Ovarian Neoplasms (1) · Prostatic Neoplasms (1) · Spinal Cord Injuries (1) · Stroke (1)
South Korea (16) · United States (1)
Chungsu Kim, Ph.D (3) · Moonyoung Kim (2) · Soon Koo Baik, M.D.,Ph.D (2) · Bumjin Lim, Ph.D (1) · Hyosang Kim (1) · Jeonghan Yoon, Ph.D. M.D. (1) · Juan Gallegos-Orozco, Ph.D (1) · Kim Hyosang (1) · Min-Soo Ahn (1) · Oh Young Bang, MD (1) · Sangryong Jeon, MD, PhD (1) · Si-Hyun Bae, M.D.,Ph.D (1) · WoongChol Kang, MD, Ph.D (1) · Yongman Kim (1)
PMID 24083670, PMID 33472925, PMID 34326007, PMID 34583525, PMID 35341320, PMID 40916722